November 23: Rift Valley Fever Phase I/IIa Clinical Trial

Integrum Scientific is selected by the Coalition for Epidemic Preparedness Innovations (CEPI) to be part of a consortium led by Wageningen Bioveterinary Research (WBVR) for a multi-site Phase I/IIa clinical trial for Rift Valley Fever. The consortium includes Batavia Biosciences BV, BunyaVax BV, CR2O | Clinical CRO BV, and the University of Veterinary Medicine Hannover. Pending regulatory approvals, Integrum will develop a mobile lab and support sample collection in Uganda and Kenya.